| Oct 8 |
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
| Oct 7 |
Halozyme Therapeutics shares fall as Wells Fargo cuts rating to equal weight
|
| Oct 7 |
Why Halozyme Therapeutics (HALO) Could Beat Earnings Estimates Again
|
| Oct 3 |
Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx for ENHANZE®
|
| Oct 2 |
High Growth Tech Stocks In The United States To Watch
|
| Oct 1 |
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
| Sep 19 |
Halozyme cut to Neutral at J.P. Morgan on valuation
|
| Sep 16 |
FDA approves Roche’s Ocrevus Zunovo with Halozyme Enhanze delivery tech
|
| Sep 13 |
(HALO) - Analyzing Halozyme Therapeutics's Short Interest
|
| Sep 13 |
Halozyme Announces FDA Approval of Roche's Subcutaneous OCREVUS ZUNOVO™ with ENHANZE® for People with Relapsing and Primary Progressive Multiple Sclerosis
|
